These data not only suggest that BMP2 is involved in the regulation of the fibrosis in the FSGS mouse model, but also suggest that BMP2 is one of the therapeutic targets in the treatment of fibrosis in the FSGS mouse model. Here, BMP2 is linked to focal segmental glomerulosclerosis.